PMID- 37081512
OWN - NLM
STAT- MEDLINE
DCOM- 20230424
LR  - 20230424
IS  - 1746-1596 (Electronic)
IS  - 1746-1596 (Linking)
VI  - 18
IP  - 1
DP  - 2023 Apr 20
TI  - Role and research progress of hematological markers in laryngeal squamous cell 
      carcinoma.
PG  - 50
LID - 10.1186/s13000-023-01335-7 [doi]
LID - 50
AB  - Laryngeal cancer is one of the most common malignant tumors of the head and neck, 
      accounting for about 20%. Due to its high disability rate, the diagnosis and 
      treatment of laryngeal cancer have always been the focus and difficulty of head 
      and neck surgery. The outcome of cancer is affected not only by tumor-related 
      factors but also by host-related factors, especially systemic inflammation, this 
      is usually reflected by a variety of hematological markers. Studies have 
      confirmed that there is a significant correlation between hematological markers 
      and the occurrence, development, and prognosis of laryngeal squamous cell 
      carcinoma (LSCC), and has a certain value in auxiliary diagnosis and prognosis 
      prediction of LSCC. We reviewed various hematological markers related to LSCC aim 
      to summarize the role and research progress of hematological markers in LSCC.
CI  - (c) 2023. The Author(s).
FAU - Qi, Hui
AU  - Qi H
AUID- ORCID: 0000-0003-3890-1405
AD  - Nursing College, Shanxi Medical University, Taiyuan, 030001, Shanxi, People's 
      Republic of China. qihuisx@163.com.
AD  - Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital 
      of Shanxi Medical University, Taiyuan, 030001, Shanxi, People's Republic of 
      China. qihuisx@163.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230420
PL  - England
TA  - Diagn Pathol
JT  - Diagnostic pathology
JID - 101251558
SB  - IM
MH  - Humans
MH  - Squamous Cell Carcinoma of Head and Neck
MH  - *Laryngeal Neoplasms/diagnosis/pathology
MH  - *Head and Neck Neoplasms
MH  - *Carcinoma, Squamous Cell/diagnosis/pathology
MH  - Prognosis
PMC - PMC10120220
OTO - NOTNLM
OT  - Hematological markers
OT  - Inflammation
OT  - Laryngeal squamous cell carcinoma
OT  - Prognosis
OT  - Tumor microenvironment
COIS- The author declare that they have no competing interests.
EDAT- 2023/04/21 00:42
MHDA- 2023/04/24 06:42
PMCR- 2023/04/20
CRDT- 2023/04/20 23:41
PHST- 2022/10/14 00:00 [received]
PHST- 2023/04/03 00:00 [accepted]
PHST- 2023/04/24 06:42 [medline]
PHST- 2023/04/21 00:42 [pubmed]
PHST- 2023/04/20 23:41 [entrez]
PHST- 2023/04/20 00:00 [pmc-release]
AID - 10.1186/s13000-023-01335-7 [pii]
AID - 1335 [pii]
AID - 10.1186/s13000-023-01335-7 [doi]
PST - epublish
SO  - Diagn Pathol. 2023 Apr 20;18(1):50. doi: 10.1186/s13000-023-01335-7.